Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- The page now shows Revision: v3.5.0 and the previous Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision note updated from v3.4.2 to v3.4.3 on the site.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; this is a maintenance update that does not alter study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange DetectedThe Study Locations section was updated with added site listings across multiple U.S. states and international districts (Jongno-gu, Seodaemun-gu, Manchester Greater), and several previously listed locations were removed. This follows revision v3.3.3.SummaryDifference2%

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.